Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Leptin Replacement in Lipodystrophy
NCT00025883Phase 2Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Oct 2001
- Primary completion
- Feb 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of metreleptin in lipodystrophy, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Oct 2001; status: completed.
02
Drugs
metreleptin
03
Conditions
lipodystrophy
Beyond the preview
Go deeper on NCT00025883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00025883.